Log in or Sign up for Free to view tailored content for your specialty!
Hidradenitis Suppurativa News
Povorcitinib outperforms placebo as treatment for hidradenitis suppurativa
Patients with hidradenitis suppurativa treated with povorcitinib achieved better outcomes than those treated with placebo, according to a study.
FDA approves Cosentyx as first IL-17A inhibitor for hidradenitis suppurativa
The FDA has approved Cosentyx for the treatment of adults with moderate to severe hidradenitis suppurativa, Novartis announced in a press release.
Log in or Sign up for Free to view tailored content for your specialty!
Bimekizumab reduces disease severity among patients with hidradenitis suppurativa
New pooled results from the BE HEARD phase 3 trials show bimekizumab reduces disease severity in patients with moderate to severe hidradenitis suppurativa, according to a UCB press release.
Medical, economic disparities impact hidradenitis suppurativa patients with skin of color
NEW YORK — Hidradenitis suppurativa disproportionally affects patients with skin of color, resulting in many management and quality of life disparities, according to a speaker at the Skin of Color Update 2023 Meeting.
World Mental Health Day: Hidden burdens of skin disease include stigmatization
Each year, WHO marks World Mental Health Day on Oct. 10 in an effort to raise awareness of mental health issues around the world and mobilize efforts to support mental health.
FDA approves Abrilada as second interchangeable adalimumab biosimilar
The FDA has approved Abrilada as the second interchangeable biosimilar to adalimumab, according to a press release from Pfizer.
Sexually diverse patients with inflammatory skin diseases experience barriers to care
Patients in sexual and gender minorities who have chronic inflammatory skin diseases often experience financial and non-financial barriers to care, according to a study.
Hormonal treatments effective, safe for women with hidradenitis suppurativa
Hormonal treatments for hidradenitis suppurativa — particularly finasteride, spironolactone and metformin — are efficacious and safe for women, but dermatologists should be aware of treatment interactions, according to a review.
Genetic variants may indicate higher risk for hidradenitis suppurativa
Genetic variants located near KLF5 and SOX9 may be associated with a higher risk for hidradenitis suppurativa, according to a study.
First patient dosed in global phase 3 trial of Rinvoq for hidradenitis suppurativa
Researchers have dosed the first patient in Step-Up HS, a phase 3 study evaluating Rinvoq for moderate to severe hidradenitis suppurativa in adults and adolescents, AbbVie announced in a press release.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read